NIP
FBRX icon

Nicholas Investment Partners’s Forte Biosciences FBRX Stock Holding History

Nicholas Investment Partners’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-133
Closed -$623K – 254
2017
Q3 		$623K Sell
133
-134
-50% -$597K 0.04% 242
2017
Q2 		$228K Buy
+267
New +$1.5M 0.02% 242

Other funds holding FBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nicholas Investment Partners's FBRX Position: Q4 2017 in Review

Nicholas Investment Partners sold out of Forte Biosciences (FBRX) in Q4 2017, closing a stake of 133 shares — an estimated $623K sold.

Nicholas Investment Partners first reported a position in FBRX in Q2 2017 and held it in 2 quarters. The position peaked at $623K in Q3 2017. 57 funds tracked by Wall St. Rank hold FBRX as of Q4 2017.

  • Nicholas Investment Partners reported no remaining Forte Biosciences position as of Q4 2017 after selling out during the quarter.
  • Nicholas Investment Partners sold 133 Forte Biosciences shares in Q4 2017, an estimated $623K.
  • Nicholas Investment Partners first reported a position in Forte Biosciences in Q2 2017 and held it in 2 quarters.
  • Nicholas Investment Partners's Forte Biosciences position peaked at $623K in Q3 2017.
  • 57 funds tracked by Wall St. Rank held Forte Biosciences as of Q4 2017.

Based on Nicholas Investment Partners's 13F filing for Q4 2017, filed 14 Feb 2018.